Cocrystal Pharma (COCP) Revenue & Revenue Breakdown
Cocrystal Pharma Revenue Highlights
00
Cocrystal Pharma Revenue by Period
Cocrystal Pharma Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | -100.00% |
2020-12-31 | $2.01M | -69.32% |
2019-12-31 | $6.56M | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | -100.00% |
2015-12-31 | $78.00K | 766.67% |
2014-12-31 | $9.00K | 100.00% |
2013-12-31 | - | -100.00% |
2012-12-31 | $17.19M | 36.38% |
2011-12-31 | $12.61M | 100.00% |
2010-12-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2007-12-31 | - | - |
Cocrystal Pharma Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $144.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | -100.00% |
2021-12-31 | $5.43K | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $510.00K | 4.29% |
2020-09-30 | $489.00K | -11.73% |
2020-06-30 | $554.00K | 20.17% |
2020-03-31 | $461.00K | 14.68% |
2019-12-31 | $402.00K | -18.29% |
2019-09-30 | $492.00K | -16.89% |
2019-06-30 | $592.00K | -88.34% |
2019-03-31 | $5.08M | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | -100.00% |
2015-09-30 | $24.00K | -11.11% |
2015-06-30 | $27.00K | - |
2015-03-31 | $27.00K | 200.00% |
2014-12-31 | $9.00K | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | -100.00% |
2013-12-31 | $-5.76M | -376.19% |
2013-09-30 | $2.09M | 6.70% |
2013-06-30 | $1.96M | -3.59% |
2013-03-31 | $2.03M | -47.64% |
2012-12-31 | $3.87M | -20.82% |
2012-09-30 | $4.89M | -0.37% |
2012-06-30 | $4.91M | 39.95% |
2012-03-31 | $3.51M | -4.29% |
2011-12-31 | $3.67M | -6.70% |
2011-09-30 | $3.93M | 52.88% |
2011-06-30 | $2.57M | 100.00% |
2011-03-31 | - | 100.00% |
2010-12-31 | - | 100.00% |
2010-09-30 | - | 100.00% |
2010-06-30 | - | 100.00% |
2010-03-31 | - | 100.00% |
2009-12-31 | - | 100.00% |
2009-09-30 | - | 100.00% |
2009-06-30 | - | 100.00% |
2009-03-31 | - | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | 100.00% |
2008-06-30 | - | 100.00% |
2008-03-31 | - | 100.00% |
2007-12-31 | - | - |
Cocrystal Pharma Revenue Breakdown
Cocrystal Pharma Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Sep 20 | Jun 20 |
---|---|---|
Collaboration Revenue | $489.00K | $554.00K |
Latest
Cocrystal Pharma Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Sep 20 | Jun 20 |
---|---|---|
Collaboration Revenue | $489.00K | $554.00K |
Latest
Cocrystal Pharma Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
IKNA | Ikena Oncology | $9.16M | - |
PULM | Pulmatrix | $7.30M | $366.00K |
CYCC | Cyclacel Pharmaceuticals | $420.00K | $10.00 |
BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
VRAX | Virax Biolabs Group | $8.56K | $76.50K |
BPTH | Bio-Path | - | - |
COCP | Cocrystal Pharma | - | - |
MBRX | Moleculin Biotech | - | - |
REVB | Revelation Biosciences | - | - |
AKTX | Akari Therapeutics | - | - |
RNXT | RenovoRx | - | - |
TPST | Tempest Therapeutics | - | - |
ALLR | Allarity Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |